F. Barbut, C. Eckert, L. Monnier, and A. , Clostridium difficile, REMIC, pp.533-539, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01252013

B. W. Buchan, T. A. Mackey, J. A. Daly, G. Alger, G. A. Denys et al.,

N. A. Ledeboer, Multicenter Clinical Evaluation of the Portrait Toxigenic C. difficile Assay for Detection of Toxigenic Clostridium difficile Strains in Clinical Stool Specimens, J Clin Microbiol, vol.50, pp.3932-3936, 2012.

A. S. Chitnis, S. M. Holzbauer, R. M. Belflower, L. G. Winston, W. M. Bamberg et al., Epidemiology of Community-Associated Clostridium difficile Infection, JAMA Intern Med, vol.173, pp.1359-1367, 2009.

, SH GTA 04 : Guide technique d'accréditation de vérification (portée A) / validation (portée B) des méthodes en biologie médicale, COFRAC, 2015.

S. H. Cohen, D. N. Gerding, S. Johnson, C. P. Kelly, V. G. Loo et al., Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA), Infect Control Hosp Epidemiol, vol.31, pp.431-455, 2010.

B. Couturier, R. Schlaberg, C. Konzak, J. Nicholes, C. Law et al., tcdA As a Diagnostic Target in a Loop-Mediated Amplification Assay for Detecting Toxigenic Clostridium difficile, Journal of Clinical Laboratory Analysis, vol.27, pp.171-176, 2013.

M. J. Crobach, T. Planche, C. Eckert, F. Barbut, E. M. Terveer et al.,

E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection, Clinical Microbiology and Infection, vol.22, pp.63-81, 2016.

S. B. Debast, M. P. Bauer, and E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clinical Microbiology and Infection, vol.20, pp.1-26, 2014.

C. Depitre, M. Delmee, V. Avesani, A. Roels, R. L'haridon et al., , 1993.

, Serogroup F strains of Clostridium difficile produce toxin B but not toxin A, Journal of Medical Microbiology, vol.38, pp.434-441

A. Goorhuis, D. Bakker, J. Corver, S. B. Debast, C. Harmanus et al., Emergence of Clostridium difficile infection due to a new, 2008.

T. Norén, M. Unemo, C. Magnusson, M. Eiserman, and A. Matussek, Evaluation of the rapid loop-mediated isothermal amplification assay Illumigene for diagnosis of Clostridium difficile in an outbreak situation, APMIS, vol.122, pp.155-160, 2014.

S. M. Novak-weekley, E. M. Marlowe, J. M. Miller, J. Cumpio, J. H. Nomura et al.,

A. Weissfeld, Clostridium difficile Testing in the Clinical Laboratory by Use of Multiple Testing Algorithms, J Clin Microbiol, vol.48, pp.889-893, 2010.

R. A. Stabler, M. He, L. Dawson, M. Martin, E. Valiente et al., Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium, Genome Biol, vol.10, p.102, 2009.

C. Viala, A. Le-monnier, N. Maataoui, C. Rousseau, A. Collignon et al., , 2012.

, Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile, J. Microbiol. Methods, vol.90, pp.83-85

J. Wust, Investigation of an Outbreak of Antibiotic-Associated Colitis by Various Typing Methods, J. CLIN. MICROBIOL, vol.16, p.6, 1982.

P. Ylisiurua, M. Koskela, O. Vainio, and H. Tuokko, Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins. Scand, J. Infect. Dis, vol.45, pp.19-25, 2013.

. Bibliographie,

B. W. Buchan, T. A. Mackey, J. A. Daly, G. Alger, G. A. Denys et al.,

N. A. Ledeboer, Multicenter Clinical Evaluation of the Portrait Toxigenic C. difficile Assay for Detection of Toxigenic Clostridium difficile Strains in Clinical Stool Specimens, J Clin Microbiol, vol.50, pp.3932-3936, 2012.

, SH GTA 06 : Guide technique d'accréditation : contrôle de qualité en biologie médicale, COFRAC, 2012.

, SH GTA 04 : Guide technique d'accréditation de vérification (portée A) / validation (portée B) des méthodes en biologie médicale, COFRAC, 2015.

, SH FORM 43 : Fiche type de vérification (portée A) / validation (portée B) d'une méthode de biologie médicale, COFRAC, 2015.

, SH REF 08 : Expression et évaluation des portées d'accréditation, COFRAC, 2017.

J. Goret, J. Blanchi, C. Eckert, S. Lacome, A. Petit et al., , 2015.

G. Hong, K. S. Park, C. Ki, and N. Y. Lee, Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples, Diagnostic Microbiology and Infectious Disease, vol.80, pp.177-180, 2014.

V. Lalande, L. Barrault, S. Wadel, C. Eckert, J. Petit et al., Evaluation of a Loop-Mediated Isothermal Amplification Assay for Diagnosis of Clostridium difficile Infections, J Clin Microbiol, vol.49, pp.2714-2716, 2011.

S. S. Magill, J. R. Edwards, W. Bamberg, Z. G. Beldavs, G. Dumyati et al.,

M. Maloney, L. Mcallister-hollod, and J. Nadle, Multistate point-prevalence survey of health care-associated Infections, New England Journal of Medicine, vol.370, pp.1198-1208, 2014.

. Meridian, C. Fiche-technique-alethia®, and . Difficile,

. Meridian, C. Fiche-technique-immunocard®, and . Gdh,

M. Neuendorf, R. Guadarrama-gonzalez, B. Lamik, and C. R. Mackenzie, A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection, BMC Microbiol, vol.16, p.19, 2016.

T. Norén, I. Alriksson, J. Andersson, T. Åkerlund, and M. Unemo, Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for Clostridium difficile Detection Challenges Cytotoxin B Cell Test and Culture as Gold Standard, J Clin Microbiol, vol.49, pp.710-711, 2011.

J. L. Staneck, L. S. Weckbach, S. D. Allen, J. A. Siders, P. H. Gilligan et al., Multicenter Evaluation of Four Methods for Clostridium difficile Detection: ImmunoCard C. difficile, Cytotoxin Assay, Culture, and Latex Agglutination, vol.34, p.4, 1996.

D. K. Turgeon, T. J. Novicki, J. Quick, L. Carlson, P. Miller et al., Six Rapid Tests for Direct Detection of Clostridium difficile and Its Toxins, 2003.

, Fecal Samples Compared with the Fibroblast Cytotoxicity Assay, J Clin Microbiol, vol.41, pp.667-670

C. Viala, A. Le-monnier, N. Maataoui, C. Rousseau, A. Collignon et al., , 2012.

, Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile, J. Microbiol. Methods, vol.90, pp.83-85

P. Ylisiurua, M. Koskela, O. Vainio, and H. Tuokko, Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins. Scand, J. Infect. Dis, vol.45, pp.19-25, 2013.

, Updated guidance on the diagnosis and reporting of Clostridium difficile, Advisory Committee Associated Infection (ARHAI, 2012.

, La transplantation de microbiote fécal et son encadrement dans les essais cliniques, Agence Nationale de Sécurité du Médicament et des produits de santé, 2016.

E. Aichinger, C. D. Schleck, W. S. Harmsen, L. M. Nyre, P. et al., Nonutility of Repeat Laboratory Testing for Detection of Clostridium difficile by Use of PCR or Enzyme Immunoassay, J Clin Microbiol, vol.46, pp.3795-3797, 2008.

A. Momani, L. A. Abughanimeh, O. Boonpherg, B. Gabriel, J. G. et al., Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium difficile Infection: A Meta-analysis and Systematic Review, 2018.

A. Saif, N. Brazier, and J. S. , The distribution of Clostridium difficile in the environment of South Wales, Journal of Medical Microbiology, vol.45, pp.133-137, 1996.

M. J. Alam, A. Anu, S. T. Walk, and K. W. Garey, Investigation of potentially pathogenic Clostridium difficile contamination in household environs, Anaerobe, vol.27, pp.31-33, 2014.

S. Ali, G. Moore, and A. P. Wilson, Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants, Journal of Hospital Infection, vol.79, pp.97-98, 2011.

I. J. Al-jumaili, M. Shibley, A. H. Lishman, and C. O. Record, Incidence and origin of Clostridium difficile in neonates, J. Clin. Microbiol, vol.19, pp.77-78, 1984.

W. N. Al-nassir, A. K. Sethi, M. M. Nerandzic, G. S. Bobulsky, R. L. Jump et al., Comparison of Clinical and Microbiological Response to Treatment of Clostridium difficile-Associated Disease with Metronidazole and Vancomycin, Clin Infect Dis, vol.47, pp.56-62, 2008.

A. S. Alvarado, S. V. Brodsky, T. Nadasdy, and N. Singh, Hemolytic uremic syndrome associated with Clostridium difficile infection, Clin. Nephrol, vol.81, pp.302-306, 2014.

A. N. Ananthakrishnan, Clostridium difficile infection: epidemiology, risk factors and management, Nature Reviews Gastroenterology & Hepatology, vol.8, pp.17-26, 2011.

G. O. Androga, J. Hart, N. F. Foster, A. Charles, D. Forbes et al., Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis, J Clin Microbiol, vol.53, pp.3702-3704, 2015.

N. G. Anosova, A. M. Brown, L. Li, N. Liu, L. E. Cole et al., Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against Clostridium difficile-associated disease in hamsters, J. Med. Microbiol, vol.62, pp.1394-1404, 2013.

J. Arimoto, N. Horita, S. Kato, A. Fuyuki, T. Higurashi et al., Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis, 2016.

S. Aslam, R. J. Hamill, and D. M. Musher, Treatment of Clostridium difficile-associated disease: old therapies and new strategies, The Lancet Infectious Diseases, vol.5, pp.549-557, 2005.

M. M. Awad, P. A. Johanesen, G. P. Carter, E. Rose, and D. Lyras, Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen, Gut Microbes, vol.5, pp.579-593, 2014.

M. Bakri, Clostridium difficile in Ready-to-Eat Salads, Scotland. Emerging Infectious Diseases Journal -CDC, vol.15, 2009.

S. M. Baliban, A. Michael, B. Shammassian, S. Mudakha, A. S. Khan et al.,

B. P. Latimer, L. Bouillaut, and M. Hunter, An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo, Infect. Immun, vol.82, pp.4080-4091, 2014.

A. Banz, A. Lantz, B. Riou, A. Foussadier, M. Miller et al., Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms, J. Clin. Microbiol, vol.56, 2018.

F. Barbut, How to eradicate Clostridium difficile from the environment, Journal of Hospital Infection, vol.89, pp.287-295, 2015.

F. Barbut, A. Richard, K. Hamadi, V. Chomette, B. Burghoffer et al., Epidemiology of Recurrences or Reinfections of Clostridium difficile-Associated Diarrhea, Journal of Clinical Microbiology, vol.38, pp.2386-2388, 2000.

F. Barbut, V. Lalande, B. Burghoffer, H. V. Thien, E. Grimprel et al., Prevalence and Genetic Characterization of Toxin A Variant Strains of Clostridium difficile among Adults and Children with Diarrhea in France, Journal of Clinical Microbiology, vol.40, pp.2079-2083, 2002.

F. Barbut, P. Mastrantonio, M. Delmée, J. Brazier, E. Kuijper et al., Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates, Clinical Microbiology and Infection, vol.13, pp.1048-1057, 2007.

F. Barbut, L. Beaugerie, and J. Petit, Clostridium difficile et pathologie digestive. Maladies infectieuses, 2008.

F. Barbut, L. Ramé, A. Petit, L. Suzon, A. De-chevigny et al., Prévalence des infections à Clostridium difficile chez les patients hospitalisés avec une diarrhée : résultats d'une étude française prospective multicentrique, La Presse Médicale, vol.44, pp.75-83, 2015.

F. Barbut, S. Bouée, L. Longepierre, M. Goldberg, C. Bensoussan et al., Excess mortality between 2007 and 2014 among patients with Clostridium difficile infection: a French health insurance database analysis, Journal of Hospital Infection, vol.98, pp.21-28, 2018.

F. Barbut, C. Eckert, L. Monnier, and A. , Clostridium difficile, REMIC, pp.533-539, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01252013

J. Barra-carrasco, C. Hernández-rocha, P. Ibáñez, A. M. Guzmán-durán, M. Álvarez-lobos et al., Clostridium difficile spores and its relevance in the persistence and transmission of the infection, Rev Chilena Infectol, vol.31, pp.694-703, 2014.

H. Barth, K. Aktories, M. R. Popoff, and B. G. Stiles, Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins, vol.68, pp.373-402, 2004.

J. G. Bartlett, Clostridium difficile: History of Its Role as an Enteric Pathogen and the Current State of Knowledge About the Organism, Clin Infect Dis, vol.18, pp.265-272, 1994.

J. G. Bartlett, Narrative Review: The New Epidemic of Clostridium difficile-Associated Enteric Disease, Annals of Internal Medicine, vol.145, p.758, 2006.

J. G. Bartlett and D. N. Gerding, Clinical Recognition and Diagnosis of Clostridium difficile Infection, Clin Infect Dis, vol.46, pp.12-18, 2008.

J. G. Bartlett and S. L. Gorbach, , 1977.

, Adv Intern Med, vol.22, pp.455-476

J. G. Bartlett, A. B. Onderdonk, R. L. Cisneros, and D. L. Kasper, Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters, J Infect Dis, vol.136, pp.701-705, 1977.

J. G. Bartlett, T. W. Chang, M. Gurwith, S. L. Gorbach, and A. B. Onderdonk, Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia, New England Journal of Medicine, vol.298, pp.531-534, 1978.

J. G. Bartlett, N. Moon, T. W. Chang, N. Taylor, and A. B. Onderdonk, Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis, Gastroenterology, vol.75, pp.778-782, 1978.

S. M. Bartsch, C. A. Umscheid, I. Nachamkin, K. Hamilton, and B. Y. Lee, Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection, Clinical Microbiology and Infection, vol.21, pp.1-77, 2015.

M. P. Bauer, D. W. Notermans, B. H. Van-benthem, J. S. Brazier, M. H. Wilcox et al., Clostridium difficile infection in Europe: a hospitalbased survey, The Lancet, vol.377, pp.63-73, 2011.

T. Beinortas, N. E. Burr, M. H. Wilcox, and V. Subramanian, Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis. The Lancet Infectious Diseases, vol.18, pp.1035-1044, 2018.

E. L. Best, W. N. Fawley, P. Parnell, and M. H. Wilcox, The Potential for Airborne Dispersal of Clostridium difficile from Symptomatic Patients, Clin Infect Dis, vol.50, pp.1450-1457, 2010.

S. Bibbò, L. R. Lopetuso, G. Ianiro, T. Di-rienzo, A. Gasbarrini et al., Role of microbiota and innate immunity in recurrent Clostridium difficile infection, J Immunol Res, p.462740, 2014.

P. Bidet, F. Barbut, V. Lalande, B. Burghoffer, and J. Petit, Development of a new PCRribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing, FEMS Microbiology Letters, vol.175, pp.261-266, 1999.

M. Biggs, T. Iqbal, E. Holden, V. Clewer, and M. I. Garvey, Effect of using fidaxomicin on recurrent Clostridium difficile infection, Journal of Hospital Infection, vol.102, pp.165-167, 2019.

G. Birgand, K. Blanckaert, A. Carbonne, B. Coignard, F. Barbut et al., Investigation of a large outbreak of Clostridium difficile PCR-ribotype 027 infections in northern France, Eurosurveillance, vol.15, 2006.

A. Blaich, R. Frei, C. Castellano, C. Kiessling, A. Geschke et al., Evaluation of two novel chemiluminescence immunoassays for the detection of Clostridium difficile glutamate dehydrogenase and toxin A&B, Journal of Microbiological Methods, vol.135, pp.63-65, 2017.

J. Blanchi, J. Goret, and F. Mégraud, Clostridium difficile Infection: A Model for Disruption of the Gut Microbiota Equilibrium, Digestive Diseases, vol.34, pp.217-220, 2016.

M. K. Bomers, M. A. Van-agtmael, H. Luik, M. C. Van-veen, C. M. Vandenbroucke-grauls et al., Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study, BMJ, vol.345, p.7396, 2012.

S. P. Borriello, 12th C. L. Oakley lecture. Pathogenesis of Clostridium difficile infection of the gut, J. Med. Microbiol, vol.33, pp.207-215, 1990.

N. A. Brown, W. D. Lebar, C. L. Young, R. E. Hankerd, and D. W. Newton, Diagnosis of Clostridium difficile infection: comparison of four methods on specimens collected in Cary-Blair transport medium and tcdB PCR on fresh versus frozen samples, 2011.

B. W. Buchan, T. A. Mackey, J. A. Daly, G. Alger, G. A. Denys et al., Multicenter Clinical Evaluation of the Portrait Toxigenic C. difficile Assay for Detection of Toxigenic Clostridium difficile Strains in Clinical Stool Specimens, J Clin Microbiol, vol.50, pp.3932-3936, 2012.

K. E. Burke and J. T. Lamont, Clostridium difficile Infection: A Worldwide Disease, Gut Liver, vol.8, pp.1-6, 2014.

S. Buyse, E. Azoulay, F. Barbut, and B. Schlemmer, Infection à Clostridium difficile : physiopathologie, diagnostic et traitement, Réanimation, vol.14, pp.255-263, 2005.

E. Calabi, S. Ward, B. Wren, T. Paxton, M. Panico et al., Molecular characterization of the surface layer proteins from Clostridium difficile, Molecular Microbiology, vol.40, pp.1187-1199, 2001.

B. P. Carpenter, E. K. Hennessey, A. M. Bryant, J. A. Khoury, and A. J. Crannage, Identification of Factors Impacting Recurrent Clostridium difficile Infection and Development of a Risk Evaluation Tool, J Pharm Pharm Sci, vol.19, pp.349-356, 2016.

K. C. Carson, L. V. Boseiwaqa, S. K. Thean, N. F. Foster, and T. V. Riley, Isolation of Clostridium difficile from faecal specimens -A comparison of chromID C. difficile agar and cycloserinecefoxitin-fructose agar, J. Med. Microbiol, vol.62, pp.1423-1427, 2013.

G. P. Carter, D. Lyras, D. L. Allen, K. E. Mackin, P. M. Howarth et al., Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator, J. Bacteriol, vol.189, pp.7290-7301, 2007.

G. P. Carter, A. Chakravorty, T. A. Pham-nguyen, S. Mileto, F. Schreiber et al., Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections, vol.6, p.551, 2015.

. Casfm, Comité de l'antibiogramme de la Société Française de Microbiologie -Recommandations, 2019.

N. Cassir, J. Delarozière, G. Dubourg, M. Delord, J. Lagier et al., A Regional Outbreak of Clostridium difficile, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01453291

, Infections in Southeastern France from a Single Long-Term Care Facility, Infection Control & Hospital Epidemiology, vol.37, pp.1337-1341

, Centre National de Référence Bactéries anaérobies et botulisme, and Laboratoires associés C. difficile, 2013.

, Centre National de Référence Bactéries anaérobies et botulisme, and Laboratoires associés C. difficile, 2014.

, Centre National de Référence Bactéries anaérobies et botulisme, and Laboratoires associés C. difficile, 2014.

T. W. Chang, S. L. Gorbach, and J. B. Bartlett, Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins, Infect. Immun, vol.22, pp.418-422, 1978.

A. S. Chitnis, S. M. Holzbauer, R. M. Belflower, L. G. Winston, W. M. Bamberg et al., Epidemiology of Community-Associated Clostridium difficile Infection, JAMA Intern Med, vol.173, pp.1359-1367, 2009.

, ECN PILLY: maladies infectieuses et et tropicales. (MED-LINE EDITIONS -EDUC), 2018.

, Code de la santé publique -Article L6221-1

, SH GTA 04 : Guide technique d'accréditation de vérification (portée A) / validation (portée B) des méthodes en biologie médicale, COFRAC, 2015.

S. H. Cohen, D. N. Gerding, S. Johnson, C. P. Kelly, V. G. Loo et al., Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA), Infect Control Hosp Epidemiol, vol.31, pp.431-455, 2010.

B. Coignard, F. Barbut, K. Blanckaert, J. M. Thiolet, I. Poujol et al., Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, p.3044, 1997.

, Comité des Universitaires des Maladies Infectieuses et Tropicales, 2016.

, Clostridium difficile Infection in Infants and Children, Committee on Infectious Diseases, vol.131, pp.196-200, 2013.

, Sanofi met fin au développement du vaccin contre Clostridium difficile, 2017.

O. A. Cornely, M. A. Miller, T. J. Louie, D. W. Crook, and S. L. Gorbach, Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin, Clin Infect Dis, vol.55, pp.154-161, 2012.

C. A. Cowardin, E. L. Buonomo, M. M. Saleh, M. G. Wilson, S. L. Burgess et al., The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia, 2016.

M. J. Crobach, O. M. Dekkers, M. H. Wilcox, and E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI), Clinical Microbiology and Infection, vol.15, pp.1053-1066, 2009.

M. J. Crobach, T. Planche, C. Eckert, F. Barbut, E. M. Terveer et al., European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection, Clinical Microbiology and Infection, vol.22, pp.63-81, 2016.

S. R. Curry, J. W. Marsh, J. L. Schlackman, and L. H. Harrison, Prevalence of Clostridium difficile in Uncooked Ground Meat Products from Pittsburgh, Pennsylvania. Appl. Environ. Microbiol, vol.78, pp.4183-4186, 2012.

K. A. Davies, C. M. Longshaw, G. L. Davis, E. Bouza, F. Barbut et al., Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), The Lancet Infectious Diseases, vol.14, pp.1208-1219, 2014.

K. A. Davies, H. Ashwin, C. M. Longshaw, D. A. Burns, G. L. Davis et al., Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), Eurosurveillance, vol.21, 2012.

S. B. Debast, M. P. Bauer, and E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clinical Microbiology and Infection, vol.20, pp.1-26, 2014.

A. Deshpande, V. Pasupuleti, D. D. Rolston, A. Jain, N. Deshpande et al., Diagnostic Accuracy of Real-time Polymerase Chain Reaction in Detection of Clostridium difficile in the Stool Samples of Patients With Suspected Clostridium difficile Infection: A Meta-Analysis, Clin Infect Dis, vol.53, pp.81-90, 2011.

A. Deshpande, V. Pasupuleti, P. Thota, C. Pant, D. D. Rolston et al., Community-associated Clostridium difficile infection and antibiotics: a metaanalysis, J. Antimicrob. Chemother, vol.68, pp.1951-1961, 2013.

K. E. Dingle, X. Didelot, T. P. Quan, D. W. Eyre, N. Stoesser et al., A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078, MBio, vol.10, 2019.

S. M. Dorp, . Van, P. Kinross, P. Gastmeier, M. Behnke et al., Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, vol.21, p.30293, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01360004

E. R. Dubberke, K. A. Reske, J. Noble-wang, A. Thompson, G. Killgore et al., Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities, American Journal of Infection Control, vol.35, pp.315-318, 2007.

H. L. Dupont, Diagnosis and management of Clostridium difficile infection, Clin. Gastroenterol. Hepatol, vol.11, pp.1216-1223, 2013.

B. Dupuy, R. Govind, A. Antunes, and S. Matamouros, Clostridium difficile toxin synthesis is negatively regulated by TcdC, Journal of Medical Microbiology, vol.57, pp.685-689, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-02444055

C. Eckert and F. Barbut, Infections à Clostridium difficile, Med Sci, vol.26, pp.153-158, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01491841

C. Eckert, V. Lalande, and F. Barbut, Diagnostic des infections à Clostridium difficile, 2011.

C. Eckert, B. Burghoffer, and F. Barbut, Contamination of ready-to-eat raw vegetables with Clostridium difficile in France, Journal of Medical Microbiology, vol.62, pp.1435-1438, 2013.

C. Eckert, B. Coignard, M. Hebert, C. Tarnaud, C. Tessier et al., Clinical and microbiological features of Clostridium difficile infections in France: The ICD-RAISIN 2009 national survey, Médecine et Maladies Infectieuses, vol.43, pp.67-74, 2013.

C. Eckert, G. Jones, and F. Barbut, Diagnosis of Clostridium difficile infection: the molecular approach, Future Microbiology, vol.8, pp.1587-1598, 2013.

C. Eckert, A. Emirian, A. Le-monnier, L. Cathala, H. De-montclos et al., Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B, New Microbes New Infect, vol.3, pp.12-17, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02022706

C. Eckert, E. Holscher, A. Petit, V. Lalande, and F. Barbut, Molecular Test Based on Isothermal Helicase-Dependent Amplification for Detection of the Clostridium difficile Toxin A Gene, J. Clin. Microbiol, vol.52, pp.2386-2389, 2014.

C. Eckert, V. Lalande, and F. Barbut, Colites à Clostridium difficile, La revue du praticien, vol.65, 2015.

C. Eckert, H. Marchandin, and F. Barbut, , 2015.

C. Eckert, H. Marchandin, L. Lemée, P. Bouvet, L. Cavalié et al., , 2015.

, Quelles méthodes utiliser pour le diagnostic des infections à Clostridium difficile ? La lettre de l'infectiologue 6

R. Eglow, C. Pothoulakis, S. Itzkowitz, E. J. Israel, C. J. O'keane et al., Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor, J. Clin. Invest, vol.90, pp.822-829, 1992.

A. A. Elkafrawy, L. Saeed, A. Tomaw, L. Numan, and S. Boyd, Adherence to the testing guidelines for Clostridium difficile toxin in stool improved the rates of hospital acquired Clostridium difficile infection, Gastroenterology, vol.156, p.894, 2019.

D. A. Enoch, R. Santos, C. J. Phillips, C. Micallef, M. E. Murphy et al., Real-world use of fidaxomicin in a large UK tertiary hospital: how effective is it for treating recurrent disease, Journal of Hospital Infection, vol.100, pp.142-146, 2018.

Z. Esfandiari, M. Jalali, H. Ezzatpanah, J. S. Weese, and M. Chamani, Prevalence and Characterization of Clostridium difficile in Beef and Mutton Meats of Isfahan Region, Iran, Jundishapur J Microbiol, vol.7, p.16771, 2014.

, Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals, European Centre for Disease Prevention and Control, 2013.

, Annual Epidemiological Report for 2016 -Clostridium difficile infections, European Centre for Disease Prevention and Control, 2018.

R. P. Fagan, C. Janoir, A. Collignon, P. Mastrantonio, I. R. Poxton et al., A proposed nomenclature for cell wall proteins of Clostridium difficile, Journal of Medical Microbiology, vol.60, pp.1225-1228, 2011.

R. Fekety, J. Silva, C. Kauffman, B. Buggy, G. Deery et al., Treatment of antibioticassociated Clostridium difficile colitis with oral vancomycin: Comparison of two dosage regimens, The American Journal of Medicine, vol.86, pp.15-19, 1989.

R. Fekety, L. V. Mcfarland, C. M. Surawicz, R. N. Greenberg, G. W. Elmer et al., Recurrent Clostridium difficile Diarrhea: Characteristics of and Risk Factors for Patients Enrolled in a Prospective, Randomized, Double-Blinded Trial, Clin Infect Dis, vol.24, pp.324-333, 1997.

J. K. Ferguson, A. C. Cheng, G. L. Gilbert, T. Gottlieb, T. Korman et al., Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice, vol.43, pp.482-487, 2011.

J. M. Finney, Gastroenterostomy for cicatrizing ulcer of the pylorus, Bull Johns Hopkins Hospital Journal, pp.53-55, 1893.

Q. Gao and H. Huang, Update on antimicrobial resistance in Clostridium difficile, Yi Chuan, vol.37, pp.458-464, 2015.

J. M. Garcáa-lechuz, S. Hernangómez, R. S. Juan, T. Peláez, L. Alcalá et al., , 2001.

, Extra-intestinal infections caused by Clostridium difficile, Clinical Microbiology and Infection, vol.7, pp.453-457

K. W. Garey, S. Sethi, Y. Yadav, and H. L. Dupont, Meta-analysis to assess risk factors for recurrent Clostridium difficile infection, Journal of Hospital Infection, vol.70, pp.298-304, 2008.

P. Garrigues, T. D. Roux, E. Wanono, and A. Mathieu, Arthrite réactionnelle à Clostridium difficile, 2016.

C. A. Gentry, P. K. Nguyen, S. Thind, G. Kurdgelashvili, G. H. Skrepnek et al., , 2019.

, Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study, Clinical Microbiology and Infection, vol.25, pp.987-993

W. L. George, R. D. Rolfe, G. K. Harding, R. Klein, C. W. Putnam et al., , 1982.

, Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis, Infection, vol.10, pp.205-208

D. N. Gerding, C. A. Muto, and R. C. Owens, Measures to control and prevent Clostridium difficile infection, Clin. Infect. Dis, vol.46, issue.1, pp.43-49, 2008.

D. N. Gerding, S. P. Sambol, J. , and S. , Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside, 2018.

R. Gerhard, S. Nottrott, J. Schoentaube, H. Tatge, A. Olling et al., Glucosylation of Rho GTPases by Clostridium difficile A triggers apoptosis in intestinal epithelial cells, J. Med. Microbiol, vol.57, pp.765-770, 2008.

B. Geric, R. J. Carman, M. Rupnik, C. W. Genheimer, S. P. Sambol et al., Binary Toxin-Producing, Large Clostridial Toxin-Negative Clostridium difficile Strains Are Enterotoxic but Do Not Cause Disease in Hamsters, J Infect Dis, vol.193, pp.1143-1150, 2006.

S. D. Goldenberg and G. L. French, Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile, J. Infect, vol.62, pp.355-362, 2011.

J. Goret, J. Blanchi, C. Eckert, S. Lacome, A. Petit et al., , 2015.

J. Goret, J. Blanchi, P. Floch, O. Peuchant, D. Chrisment et al., Impact of the introduction of a nucleic acid amplification test for Clostridium difficile diagnosis on stool rejection policies, Gut Pathog, vol.10, 2018.

R. Govind and B. Dupuy, Secretion of Clostridium difficile Toxins A and B Requires the Holinlike Protein TcdE, PLOS Pathogens, vol.8, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-02440910

I. C. Hall and E. Toole, Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis, Am J Dis Child, vol.49, pp.390-402, 1935.

C. Hennequin, F. Porcheray, A. Waligora-dupriet, A. Collignon, M. Barc et al., GroEL (Hsp60) of Clostridium difficile is involved in cell adherence, Microbiology (Reading, Engl.), vol.147, pp.87-96, 2001.
URL : https://hal.archives-ouvertes.fr/hal-01899021

C. Hennequin, C. Janoir, M. Barc, A. Collignon, and T. Karjalainen, Identification and characterization of a fibronectin-binding protein from Clostridium difficile, Microbiology (Reading, Engl.), vol.149, pp.2779-2787, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01899010

M. P. Hensgens, E. C. Keessen, M. M. Squire, T. V. Riley, M. G. Koene et al., Clostridium difficile infection in the community: a zoonotic disease?, Clinical Microbiology and Infection, vol.18, pp.635-645, 2012.

J. J. Hirvonen and S. Kaukoranta, Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs, Eur J Clin Microbiol Infect Dis, vol.34, pp.1005-1009, 2015.

G. Hong, K. S. Park, C. Ki, and N. Y. Lee, Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples, Diagnostic Microbiology and Infectious Disease, vol.80, pp.177-180, 2014.

D. G. Hoover and A. Rodriguez-palacios, Transmission of Clostridium difficile in Foods, Infectious Disease Clinics of North America, vol.27, pp.675-685, 2013.

M. Y. Hu, K. Katchar, L. Kyne, S. Maroo, S. Tummala et al., Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection, Gastroenterology, vol.136, pp.1206-1214, 2009.

H. Huang, A. Weintraub, H. Fang, and C. E. Nord, Antimicrobial resistance in Clostridium difficile, International Journal of Antimicrobial Agents, vol.34, pp.516-522, 2009.

R. M. Humphries, D. Z. Uslan, R. , and Z. , Performance of Clostridium difficile Toxin Enzyme Immunoassay and Nucleic Acid Amplification Tests Stratified by Patient Disease Severity, Journal of Clinical Microbiology, vol.51, pp.869-873, 2013.

, Infections à Clostridium difficile : situation épidémiologique, France, 2009.

, Conduite à tenir : diagnostic, investigation, surveillance, et principes de prévention et de maîtrise des infections à Clostridium difficile, Institut de Veille Sanitaire -Réseau d'Alerte, d'Investigation et de Surveillance des Infections Nosocomiales, 2006.

S. Janezic, M. Potocnik, V. Zidaric, and M. Rupnik, Highly Divergent Clostridium difficile Strains Isolated from the Environment, PLOS ONE, vol.11, 2016.

S. Jangi and J. T. Lamont, Asymptomatic Colonization by Clostridium difficile in Infants: Implications for Disease in Later Life, Journal of Pediatric Gastroenterology and Nutrition, vol.51, pp.2-7, 2010.

T. Jank, A. , and K. , Structure and mode of action of clostridial glucosylating toxins: the ABCD model, Trends in Microbiology, vol.16, pp.222-229, 2008.

C. M. Jardine, R. J. Reid-smith, J. Rousseau, and J. S. Weese, Detection of Clostridium difficile in Small and Medium-sized Wild Mammals in Southern Ontario, Canada. Jwdi, vol.49, pp.418-421, 2013.

R. Joseph, D. Demeyer, D. Vanrenterghem, . Van-den, R. Berg et al., , 2005.

, First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium, Euro Surveill, vol.10

I. Jullian-desayes, C. Landelle, M. Mallaret, C. Brun-buisson, and F. Barbut, Clostridium difficile contamination of health care workers' hands and its potential contribution to the spread of infection: Review of the literature, American Journal of Infection Control, vol.45, pp.51-58, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02012405

R. L. Jump, M. J. Pultz, and C. J. Donskey, Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and Clostridium difficile-associated diarrhea?, Antimicrobial Agents and Chemotherapy, vol.51, pp.2883-2887, 2007.

I. Just, G. , and R. , Large clostridial cytotoxins, Rev. Physiol. Biochem. Pharmacol, vol.152, pp.23-47, 2004.

E. Keessen, C. Harmanus, W. Dohmen, and L. Lipman, Clostridium difficile Infection Associated with Pig Farms, Emerging Infectious Diseases journal -CDC, vol.19, issue.6, 2013.

M. Y. Khan and W. H. Hall, Staphylococcal Enterocolitis-Treatment with Oral Vancomycin, Annals of Internal Medicine, vol.65, 1966.

S. Khanna, D. S. Pardi, S. L. Aronson, P. P. Kammer, R. Orenstein et al., The Epidemiology of Community-acquired Clostridium difficile infection: A population-based study, Am J Gastroenterol, vol.107, pp.89-95, 2012.

J. Kim, M. Seo, J. O. Kang, Y. Kim, S. Hong et al., Clinical characteristics of relapses and re-infections in Clostridium difficile infection, Clinical Microbiology and Infection, vol.20, pp.1198-1204, 2014.

D. R. Knight, B. Elliott, B. J. Chang, T. T. Perkins, and T. V. Riley, Diversity and Evolution in the Genome of Clostridium difficile, Clin Microbiol Rev, vol.28, pp.721-741, 2015.

F. C. Knoop, M. Owens, and I. C. Crocker, Clostridium difficile: clinical disease and diagnosis, 1993.

, Clin Microbiol Rev, vol.6, pp.251-265

A. Kola, M. Behnke, P. Gastmeier, S. M. Dorp, . Van et al., ECDC), 2015.

K. Koss, M. A. Clark, D. S. Sanders, D. Morton, M. R. Keighley et al., The outcome of surgery in fulminant Clostridium difficile colitis, Colorectal Disease, vol.8, pp.149-154, 2006.

A. Kovacs-simon, R. Leuzzi, M. Kasendra, N. Minton, R. W. Titball et al., , 2014.

, Lipoprotein CD0873 is a novel adhesin of Clostridium difficile, J. Infect. Dis, vol.210, pp.274-284

S. A. Kuehne, S. T. Cartman, J. T. Heap, M. L. Kelly, A. Cockayne et al., The role of toxin A and toxin B in Clostridium difficile infection, Nature, vol.467, pp.711-713, 2010.

S. A. Kuehne, M. M. Collery, M. L. Kelly, S. T. Cartman, A. Cockayne et al., , 2014.

, Importance of Toxin A, Toxin B, and CDT in virulence of an epidemic Clostridium difficile strain, The Journal of Infectious Diseases, vol.209, pp.83-86

E. J. Kuijper, B. Coignard, and P. Tüll, Emergence of Clostridium difficile-associated disease in North America and Europe, Clinical Microbiology and Infection, vol.12, pp.2-18, 2006.

E. J. Kuijper, . Van-den, R. J. Berg, and S. Debast, Emerging Infectious Diseases Journal -CDC, vol.12, 2006.

J. H. Kwon, C. Lanzas, K. A. Reske, T. Hink, S. M. Seiler et al., An Evaluation of Food as a Potential Source for Clostridium difficileAcquisition in Hospitalized Patients, Infect Control Hosp Epidemiol, vol.37, pp.1401-1407, 2016.

L. Kyne, M. Warny, A. Qamar, and C. P. Kelly, Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A, New England Journal of Medicine, vol.342, pp.390-397, 2000.

L. Kyne, M. Warny, A. Qamar, and C. P. Kelly, Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea, The Lancet, vol.357, pp.189-193, 2001.

V. Lalande, F. Barbut, and J. Petit, Diagnostic bactériologique des infections liées à Clostridium difficile, pp.57-63, 2004.

V. Lalande, L. Barrault, S. Wadel, C. Eckert, J. Petit et al., Evaluation of a Loop-Mediated Isothermal Amplification Assay for Diagnosis of Clostridium difficile Infections, J Clin Microbiol, vol.49, pp.2714-2716, 2011.

J. T. Lamont, E. Theodore, and . Woodward-award, How bacterial enterotoxins work: insights from in vivo studies, Trans. Am. Clin. Climatol. Assoc, vol.113, pp.180-181, 2002.

P. Lantz, M. Matsson, T. Wadström, and P. Rådström, Removal of PCR inhibitors from human faecal samples through the use of an aqueous two-phase system for sample preparation prior to PCR, Journal of Microbiological Methods, vol.28, pp.159-167, 1997.

T. D. Lawley, N. J. Croucher, L. Yu, S. Clare, M. Sebaihia et al., Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores, J. Bacteriol, vol.191, pp.5377-5386, 2009.

P. A. Lawson, D. M. Citron, K. L. Tyrrell, and S. M. Finegold, Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938, Anaerobe, vol.40, pp.95-99, 2016.

R. Le-guern, S. Herwegh, R. Courcol, and F. Wallet, Molecular methods in the diagnosis of Clostridium difficile infections: an update, Expert Rev. Mol. Diagn, vol.13, pp.681-692, 2013.

D. A. Leffler and J. T. Lamont, Treatment of Clostridium difficile-Associated Disease, Gastroenterology, vol.136, pp.1899-1912, 2009.

D. A. Leffler and J. T. Lamont, Clostridium difficile infection, N. Engl. J. Med, vol.372, pp.1539-1548, 2015.

L. Lemée and J. Pons, Les méthodes de typage appliquées à Clostridium difficile: principes et intérêts. Revue française des laboratoires 7, 2004.

F. C. Lessa, C. V. Gould, and L. C. Mcdonald, Current Status of Clostridium difficile Infection Epidemiology, Clin Infect Dis, vol.55, pp.65-70, 2012.

J. Li, C. Xiong, Y. Liu, J. Liang, and X. Zhou, Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification, Front Plant Sci, vol.7, 1956.

V. G. Loo, M. Oughton, A. Bourgault, M. Kelly, K. Dewar et al., A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality, The New England Journal of Medicine, vol.8, 2005.

V. G. Loo, A. Bourgault, L. Poirier, F. Lamothe, S. Michaud et al., Host and pathogen factors for Clostridium difficile infection and colonization, New England Journal of Medicine, vol.365, pp.1693-1703, 2011.

T. J. Louie, K. Cannon, B. Byrne, J. Emery, L. Ward et al., , 2012.

, Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI, Clin Infect Dis, vol.55, pp.132-142

I. Lowy, D. C. Molrine, B. A. Leav, B. M. Blair, R. Baxter et al., Treatment with Monoclonal Antibodies against Clostridium difficile Toxins, vol.362, pp.197-205, 2010.

D. Lyras, J. R. O'connor, P. M. Howarth, S. P. Sambol, G. P. Carter et al., Toxin B is essential for virulence of Clostridium difficile, Nature, vol.458, pp.1176-1179, 2009.

S. S. Magill, J. R. Edwards, W. Bamberg, Z. G. Beldavs, G. Dumyati et al., Multistate point-prevalence survey of health care-associated Infections, New England Journal of Medicine, vol.370, pp.1198-1208, 2014.

Y. C. Manabe, J. M. Vinetz, R. D. Moore, C. Merz, P. Charache et al., , 1995.

, Clostridium difficile colitis: an efficient clinical approach to diagnosis, Ann. Intern. Med, vol.123, pp.835-840

C. F. Manthey, L. Eckmann, and V. Fuhrmann, Therapy for Clostridium difficile infection -any news beyond Metronidazole and Vancomycin?, Expert Review of Clinical Pharmacology, vol.10, pp.1239-1250, 2017.

L. M. Marler, J. A. Siders, L. C. Wolters, Y. Pettigrew, B. L. Skitt et al., Comparison of five cultural procedures for isolation of Clostridium difficile from stools, J. Clin. Microbiol, vol.30, pp.514-516, 1992.

A. Martínez-meléndez, A. Camacho-ortiz, R. Morfin-otero, H. J. Maldonado-garza, L. Villarreal-treviño et al., Current knowledge on the laboratory diagnosis of Clostridium difficile infection, World Journal of Gastroenterology, vol.23, p.1552, 2017.

M. J. Mashock, M. L. Faron, B. W. Buchan, and N. A. Ledeboer, Evaluation of Copan FecalSwab as Specimen Type for Use in Xpert C. difficile Assay, Journal of Clinical Microbiology, vol.55, pp.3123-3129, 2017.

S. Matamouros, P. England, and B. Dupuy, Clostridium difficile toxin expression is inhibited by the novel regulator TcdC, Molecular Microbiology, vol.64, pp.1274-1288, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-02444062

E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari et al., Extraintestinal Clostridium difficile Infections, Clin Infect Dis, vol.57, pp.148-153, 2013.

S. Maugat, V. Ponties, and M. Colomb-cotinat, Bilan 2001-2017 des signalements externes d'infections nosocomiales. Part des signalements impliquant une bactérie multirésistante, 2018.

J. Mccarthy and N. Stingemore, Clostridium difficile infection of a prosthetic joint presenting 12 months after antibiotic-associated diarrhoea, Journal of Infection, vol.39, pp.94-96, 1999.

L. C. Mcdonald, R. C. Owens, J. , and S. , An epidemic, toxin gene-variant strain of Clostridium difficile, The New England Journal of Medicine, vol.9, 2005.

L. C. Mcdonald, D. N. Gerding, S. Johnson, J. S. Bakken, K. C. Carroll et al., Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), Clin Infect Dis, vol.66, pp.1-48, 2018.

L. V. Mcfarland, Antibiotic-associated diarrhea: epidemiology, trends and treatment, Future Microbiology, vol.3, pp.563-578, 2008.

L. V. Mcfarland, Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections, Anaerobe, vol.15, pp.274-280, 2009.

L. V. Mcfarland, M. E. Mulligan, R. Y. Kwok, and W. E. Stamm, Nosocomial Acquisition of Clostridium difficile Infection, New England Journal of Medicine, vol.320, pp.204-210, 1989.

D. Metcalf, B. P. Avery, N. Janecko, N. Matic, R. Reid-smith et al., Clostridium difficile in seafood and fish, Anaerobe, vol.17, pp.85-86, 2011.

M. Monot, C. Eckert, A. Lemire, A. Hamiot, T. Dubois et al., Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01271725

L. Monteiro, D. Bonnemaison, A. Vekris, K. G. Petry, J. Bonnet et al., Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model, J Clin Microbiol, vol.35, pp.995-998, 1997.

M. D. Neal, J. C. Alverdy, D. E. Hall, R. L. Simmons, and B. S. Zuckerbraun, Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, Annals of Surgery, vol.254, p.423, 2011.

M. Neuendorf, R. Guadarrama-gonzalez, B. Lamik, and C. R. Mackenzie, A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection, BMC Microbiol, vol.16, p.19, 2016.

T. Norén, I. Alriksson, J. Andersson, T. Åkerlund, and M. Unemo, Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for Clostridium difficile Detection Challenges Cytotoxin B Cell Test and Culture as Gold Standard, J Clin Microbiol, vol.49, pp.710-711, 2011.

T. Norén, M. Unemo, C. Magnusson, M. Eiserman, and A. Matussek, Evaluation of the rapid loop-mediated isothermal amplification assay Illumigene for diagnosis of Clostridium difficile in an outbreak situation, APMIS, vol.122, pp.155-160, 2014.

T. Notomi, H. Okayama, H. Masubuchi, T. Yonekawa, K. Watanabe et al., Loop-mediated isothermal amplification of DNA, Nucleic Acids Res, vol.28, pp.63-63, 2000.

S. C. Numan, P. Veldkamp, E. J. Kuijper, R. J. Berg, . Van-den et al., Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses, Gut, vol.56, pp.888-889, 2007.

S. Oikarinen, S. Tauriainen, H. Viskari, O. Simell, M. Knip et al., PCR inhibition in stool samples in relation to age of infants, J. Clin. Virol, vol.44, pp.211-214, 2009.

A. Oren and M. Rupnik, Clostridium difficile and Clostridioides difficile: Two validly published and correct names, Anaerobe, vol.52, pp.125-126, 2018.

J. A. Otter, S. Yezli, J. A. Salkeld, and G. L. French, Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings, American Journal of Infection Control, vol.41, pp.6-11, 2013.

D. Paredes-sabja, A. Shen, and J. A. Sorg, Clostridium difficile spore biology: sporulation, germination, and spore structural proteins, Trends in Microbiology, vol.22, pp.406-416, 2014.

T. Peláez, E. Cercenado, L. Alcalá, M. Marín, A. Martín-lópez et al., Metronidazole resistance in Clostridium difficile is heterogeneous, J. Clin. Microbiol, vol.46, pp.3028-3032, 2008.

J. Pépin, L. Valiquette, C. , and B. , Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec, CMAJ, vol.173, pp.1037-1042, 2005.

J. Pépin, N. Saheb, M. Coulombe, M. Alary, M. Corriveau et al., Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec, Clin Infect Dis, vol.41, pp.1254-1260, 2005.

P. Permpoonpattana, E. H. Tolls, R. Nadem, S. Tan, A. Brisson et al., Surface layers of Clostridium difficile endospores, J. Bacteriol, vol.193, pp.6461-6470, 2011.

T. D. Planche, K. A. Davies, P. G. Coen, J. M. Finney, I. M. Monahan et al., Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection, The Lancet Infectious Diseases, vol.13, pp.936-945, 2013.

C. R. Polage, C. E. Gyorke, M. A. Kennedy, J. L. Leslie, D. L. Chin et al., Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era, JAMA Intern Med, vol.175, pp.1792-1801, 2015.

N. R. Pollock, A. Banz, X. Chen, D. Williams, H. Xu et al., Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay, Clin Infect Dis, vol.68, pp.78-86, 2019.

M. R. Popoff, E. J. Rubin, D. M. Gill, and P. Boquet, Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain, Infect Immun, vol.56, pp.2299-2306, 1988.

. Quamic, Comité Qualité de la Société Française de Microbiologie, 2016.

D. Rabold, W. Espelage, M. A. Sin, T. Eckmanns, A. Schneeberg et al., The zoonotic potential of Clostridium difficile from small companion animals and their owners, PLOS ONE, vol.13, 2018.

C. Rodriguez, B. Taminiau, J. Van-broeck, M. Delmée, and G. Daube, Clostridium difficile in Food and Animals: A Comprehensive Review, Adv. Exp. Med. Biol, vol.932, pp.65-92, 2016.

A. Rodriguez-palacios and J. T. Lejeune, Moist-heat resistance, spore aging, and superdormancy in Clostridium difficile, Appl. Environ. Microbiol, vol.77, pp.3085-3091, 2011.

A. Rodriguez-palacios, S. Ilic, and J. T. Lejeune, Food Indwelling Clostridium difficile in Naturally Contaminated Household Meals: Data for Expanded Risk Mathematical Predictions, Infection Control & Hospital Epidemiology, vol.38, pp.509-510, 2017.

R. D. Rolfe and W. Song, Purification of a functional receptor for Clostridium difficile toxin A from intestinal brush border membranes of infant hamsters, Clin. Infect. Dis, vol.16, pp.219-227, 1993.

C. Rousseau, I. Poilane, F. Diakite, L. Feghoul, P. Cruaud et al., Comparaison de trois milieux pour la culture de Clostridium difficile : intérêt des milieux favorisant la germination des spores ?, Pathologie Biologie, vol.58, pp.58-61, 2010.

C. Rousseau, I. Poilane, L. De-pontual, A. Maherault, A. Le-monnier et al., , 2012.

, Clostridium difficile Carriage in Healthy Infants in the Community: A Potential Reservoir for Pathogenic Strains, Clin Infect Dis, vol.55, pp.1209-1215

M. Rupnik, M. H. Wilcox, and D. N. Gerding, Clostridium difficile infection: new developments in epidemiology and pathogenesis, Nature Reviews Microbiology, vol.7, pp.526-536, 2009.

W. A. Rutala, M. F. Gergen, and D. J. Weber, Efficacy of different cleaning and disinfection methods against Clostridium difficile spores: importance of physical removal versus sporicidal inactivation, Infect Control Hosp Epidemiol, vol.33, pp.1255-1258, 2012.

R. Saginur, R. Fogel, L. Begin, B. Cohen, and J. Mendelson, Splenic abscess due to Clostridium difficile, J. Infect. Dis, vol.147, p.1105, 1983.

N. Salles, Clostridium difficile: prévalence, conséquences et traitement chez la personne âgée. Les cahiers de l'année gérontologique 1, pp.73-79, 2009.

J. Sandlund, A. Bartolome, A. Almazan, S. Tam, S. Biscocho et al., Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology, Journal of Clinical Microbiology, vol.56, pp.908-926, 2018.

C. Schmidt, B. Löffler, A. , and G. , Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile, Diagn. Microbiol. Infect. Dis, vol.59, pp.1-5, 2007.

C. Schwan, B. Stecher, T. Tzivelekidis, M. Ham, . Van et al., Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria, PLOS Pathogens, vol.5, 2009.

C. Schwan, A. S. Kruppke, T. Nölke, L. Schumacher, F. Koch-nolte et al., Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.2313-2318, 2014.

P. Seksik, Colite à Clostridium difficile : quelle prise en charge en 2019 ? GASTRO ENTÉROLOGIE 10, 2019.

C. Simango, Prevalence of Clostridium difficile in the environment in a rural community in Zimbabwe, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.100, pp.1146-1150, 2006.

A. E. Simor, Diagnosis, Management, and Prevention of Clostridium difficile Infection in Long-Term Care Facilities: A, Review. Journal of the American Geriatrics Society, vol.58, pp.1556-1564, 2010.

A. J. Simpson, S. S. Das, and S. Tabaqchali, Nosocomial empyema caused by Clostridium difficile, J. Clin. Pathol, vol.49, pp.172-173, 1996.

A. Smith, Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxinproducing strains in Canada and the US. Weekly Releases, 1997.

L. Smith, . Ds, and E. O. King, Occurence of Clostridium difficile in infections of man, J Bacteriol, vol.84, pp.65-67, 1962.

W. K. Smits, D. Lyras, D. B. Lacy, M. H. Wilcox, and E. J. Kuijper, Clostridium difficile infection, 2016.

M. L. Snyder, Further Studies on Bacillus Difficilis (Hall and O'Toole), J Infect Dis, vol.60, pp.223-231, 1937.

M. L. Snyder, The Normal Fecal Flora of Infants between Two Weeks and One Year of AgeI. Serial Studies, J Infect Dis, vol.66, pp.1-16, 1940.

L. Song, M. Zhao, D. C. Duffy, J. Hansen, K. Shields et al., Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool, J Clin Microbiol, vol.53, pp.3204-3212, 2015.

P. Spigaglia, F. Barbanti, P. Mastrantonio, J. S. Brazier, F. Barbut et al., Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe, Group on Clostridium difficile (ESGCD), vol.57, pp.784-789, 2008.

J. L. Staneck, L. S. Weckbach, S. D. Allen, J. A. Siders, P. H. Gilligan et al., Multicenter Evaluation of Four Methods for Clostridium difficile Detection: ImmunoCard C. difficile, Cytotoxin Assay, Culture, and Latex Agglutination, vol.34, p.4, 1996.

D. B. Stewart, C. S. Hollenbeak, and M. Z. Wilson, Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review, Colorectal Disease, vol.15, pp.798-804, 2013.

X. Sun, H. Wang, Y. Zhang, K. Chen, B. Davis et al., Mouse relapse model of Clostridium difficile infection, Infect. Immun, vol.79, pp.2856-2864, 2011.

C. Sutens, P. Kinross, and E. Centre, European surveillance of Clostridium difficile infections surveillance protocol version 2.3, ECDC), 2017.

P. D. Tamma and T. J. Sandora, Clostridium difficile Infection in Children: Current State and Unanswered Questions, J Pediatric Infect Dis Soc, vol.1, pp.230-243, 2012.

F. J. Tedesco, Clindamycin-Associated Colitis: A Prospective Study, Annals of Internal Medicine, vol.81, p.429, 1974.

F. J. Tedesco, Pseudomembranous Colitis: Pathogenesis and Therapy, Medical Clinics of North America, vol.66, pp.655-664, 1982.

A. K. Thabit and D. P. Nicolau, Lack of Correlation between Bristol Stool Scale and Quantitative Bacterial Load in Clostridium difficile Infection, Infect Dis (Auckl), vol.8, pp.1-4, 2015.

J. M. Thiolet, S. Vaux, M. Lamy, and A. Gautier, Enquête nationale de prévalence des infections nosocomiales et des traitements antiinfectieux en établissements de santé, 2012.

D. F. Thomas, M. Malone, D. S. Fernie, R. Bayston, and L. Spitz, Association between Clostridium difficile and enterocolitis in Hirshsprung's disease, The Lancet, vol.319, pp.78-79, 1982.

C. M. Thorpe, A. V. Kane, J. Chang, A. Tai, R. J. Vickers et al., Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin, PLOS ONE, vol.13, 2018.

A. Trifan, C. Stanciu, I. Girleanu, O. C. Stoica, A. M. Singeap et al., Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis, World J. Gastroenterol, vol.23, pp.6500-6515, 2017.

L. Tulli, S. Marchi, R. Petracca, H. A. Shaw, N. F. Fairweather et al., CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen, Cell. Microbiol, vol.15, pp.1674-1687, 2013.

D. K. Turgeon, T. J. Novicki, J. Quick, L. Carlson, P. Miller et al., Six Rapid Tests for Direct Detection of Clostridium difficile and Its Toxins in Fecal Samples Compared with the Fibroblast Cytotoxicity Assay, J Clin Microbiol, vol.41, pp.667-670, 2003.

N. Ulger-toprak, G. Balkose, D. Durak, E. Dulundu, T. Demirba? et al., Clostridium difficile: A rare cause of pyogenic liver abscess, Anaerobe, vol.42, pp.108-110, 2016.

P. Verity, M. H. Wilcox, W. Fawley, P. , and P. , Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms, Journal of Hospital Infection, vol.49, pp.204-209, 2001.

C. Viala, A. Le-monnier, N. Maataoui, C. Rousseau, A. Collignon et al., , 2012.

, Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile, J. Microbiol. Methods, vol.90, pp.83-85

R. J. Vickers, G. S. Tillotson, R. Nathan, S. Hazan, J. Pullman et al., Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, activecontrolled, non-inferiority study, The Lancet Infectious Diseases, vol.17, pp.735-744, 2017.

R. Vonberg, E. J. Kuijper, M. H. Wilcox, F. Barbut, P. Tüll et al., Infection control measures to limit the spread of Clostridium difficile, Clinical Microbiology and Infection, vol.14, pp.2-20, 2008.

A. Walkty, P. R. Lagacé-wiens, K. Manickam, H. Adam, P. Pieroni et al., Evaluation of an Algorithmic Approach in Comparison with the Illumigene Assay for Laboratory Diagnosis of Clostridium difficile Infection, Journal of Clinical Microbiology, vol.51, pp.1152-1157, 2013.

M. Warny, J. Pepin, A. Fang, G. Killgore, A. Thompson et al., Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe, The Lancet, vol.366, pp.1079-1084, 2005.

M. H. Wilcox, L. Mooney, R. Bendall, C. D. Settle, and W. N. Fawley, A case-control study of community-associated Clostridium difficile infection, J Antimicrob Chemother, vol.62, pp.388-396, 2008.

M. H. Wilcox, D. N. Gerding, I. R. Poxton, C. Kelly, R. Nathan et al., Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection, New England Journal of Medicine, vol.376, pp.305-317, 2017.

C. Xu, J. S. Weese, C. Flemming, J. Odumeru, and K. Warriner, Fate of Clostridium difficile during wastewater treatment and incidence in Southern Ontario watersheds, Journal of Applied Microbiology, vol.117, pp.891-904, 2014.

P. Ylisiurua, M. Koskela, O. Vainio, and H. Tuokko, Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins. Scand, J. Infect. Dis, vol.45, pp.19-25, 2013.

S. Yui, S. Ali, M. Muzslay, A. Jeanes, and A. P. Wilson, Identification of Clostridium difficile Reservoirs in The Patient Environment and Efficacy of Aerial Hydrogen Peroxide Decontamination, Infection Control & Hospital Epidemiology, vol.38, pp.1487-1492, 2017.

F. A. Zar, S. R. Bakkanagari, K. M. Moorthi, and M. B. Davis, A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity, Clin Infect Dis, vol.45, pp.302-307, 2007.

P. D. Ziakas, I. M. Zacharioudakis, F. N. Zervou, C. Grigoras, E. E. Pliakos et al., , 2015.

, Asymptomatic Carriers of Toxigenic Clostridium difficile in Long-Term Care Facilities: A Meta-Analysis of Prevalence and Risk Factors, PLOS ONE, vol.10, 117195.